UBS Adjusts Price Target for Northrop Grumman (NOC) Amid Growth Challenges | NOC Stock News

Author's Avatar
Apr 23, 2025
Article's Main Image

UBS has revised its price target for Northrop Grumman (NOC, Financial), reducing it from $583 to $571, while maintaining a Buy rating on the stock. This adjustment reflects the anticipated challenges in achieving the aerospace and defense company's guidance for 2025. Despite these hurdles, UBS highlights the potential for long-term growth due to Northrop Grumman's substantial backlog of orders. This backlog is seen as a significant opportunity for the company to capitalize on in the future, encouraging a positive outlook among investors.

Wall Street Analysts Forecast

1915030980448645120.png

Based on the one-year price targets offered by 21 analysts, the average target price for Northrop Grumman Corp (NOC, Financial) is $553.16 with a high estimate of $625.00 and a low estimate of $480.00. The average target implies an upside of 19.19% from the current price of $464.08. More detailed estimate data can be found on the Northrop Grumman Corp (NOC) Forecast page.

Based on the consensus recommendation from 25 brokerage firms, Northrop Grumman Corp's (NOC, Financial) average brokerage recommendation is currently 2.3, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Northrop Grumman Corp (NOC, Financial) in one year is $558.29, suggesting a upside of 20.3% from the current price of $464.08. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Northrop Grumman Corp (NOC) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.